The invention relates to the sodium salt of (1R,2S,5R)-7-oxo-6-sulfooxy-1,6- diazabicyclo[3.2.1]octane-2-carboxamide in hydrated or anhydrous crystallized enantiomeric form and in particular in the novel crystallized polymorphic and pseudopolymorphic forms "A", "B", "D" and "E" defined in the application, as well as the method of preparation. The compound of the invention can be used as a medicament, in particular a beta-lactamase inhibitor.
本发明涉及(1R,2S,5R)-7-氧代-6-
磺酸基氧代-1,6-二氮杂
双环[3.2.1]辛烷-2-羧酰胺的钠盐,其以
水合或无
水结晶对映体形式存在,特别是在本申请中定义的新的结晶多态和伪多态形式“A”、“B”、“D”和“E”中,以及其制备方法。本发明的化合物可以用作药物,特别是β-内酰胺酶抑制剂。